NCSTN and Alzheimer disease: However, we did observe a significant inverse correlation between membralin and nicastrin levels in combined non-AD and AD patient samples (Fig. 5f, R2 = 0.3982, P = 0.00116), which strongly suggests that membralin may modulate nicastrin levels and γ-secretase activity in aged brain and AD pathogenesis.